Vestal Point Capital, LP - Jun 30, 2025 SCHEDULE 13G/A Report for Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX)

Filing Manager: Vestal Point Capital, LP
Reporting Manager: Vestal Point Capital, LP
Security: Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: BCAX
Shares outstanding: 54.3M shares
Disclosed Ownership: 5M shares
Ownership: 9.2%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 03:57 PM
Date of event: Jun 30, 2025
Previous filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vestal Point Capital, LP	9.2%	5M	0	5M	/s/ Ryan Wilder	By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder	9.2%	5M	0	5M	/s/ Ryan Wilder	Ryan Wilder, Individually